| IRLAB THERAP. AB A |
| Schweden |
| Gesundheit |
| SE0012675361 / A2PLBE |
| 6IRA (Frankfurt) |
| FRA:6IRA, ETR:6IRA, 6IRA:GR |
| - |
| https://www.irlab.se/ |
|
Irlab Therapeutics AB, a prominent biotechnology company, focuses on developing transformative therapies for central nervous system (CNS) disorders. Positioned at the cutting edge of pharmaceutical innovation, the company dedicates its efforts to res..
>Volltext.. |
| 11.15 Mio. EUR |
| 6.39 Mio. EUR |
| 5.39 Mio. EUR |
| -8.25 Mio. EUR |
| -10.31 Mio. EUR |
| -0.17 EUR |
| 2.81 Mio. EUR |
| 7.67 Mio. EUR |
| -5.18 Mio. EUR |
| 0.76 |
| -39.28% |
| -32.34% |
| - |
| - |
| - |
| - |
| IRLAB |
| 05.04.26 |
|